NQO1 and bladder transitional cell carcinoma: In addition, the NQO1 methylation levels were significantly lower in uterine carcinosarcoma, liver hepatocellular carcinoma, pancreatic adenocarcinoma, bladder urothelial carcinoma, bladder urothelial carcinoma, and lung squamous cell carcinoma (Supplementary Figure S2B).